|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 59.25 USD | +1.01% |
|
-2.20% | +25.77% |
| 07-15 | Bruker Acquires Noscendo's Disqver Clinical Metagenomics Platform | MT |
| 07-14 | Bruker Corporation acquired DISQVER Clinical Metagenomics Platform of Noscendo GmbH. | CI |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
| 9.02B | BBB | ||||||||
| 202B | BBB | ||||||||
| 145B | A | ||||||||
| 142B | BBB | ||||||||
| 66.32B | BBB | ||||||||
| 50.58B | AAA | ||||||||
| 44.81B | BBB | ||||||||
| 38.44B | AAA | ||||||||
| 37.13B | AAA | ||||||||
| 29.89B | A | ||||||||
| 29.25B | A | ||||||||
| 28.78B | BBB | ||||||||
| 26.84B | AA | ||||||||
| 25.98B | B | ||||||||
| 12.46B | AA | ||||||||
| 11.42B | BB | ||||||||
| 4.37B | - | A | - | - | |||||
| 3.74B | - | - | - | - | - | - | - | ||
| 3.7B | - | - | - | - | - | - | - | ||
| 3.38B | A | - | |||||||
| Average | 45.78B | A | |||||||
| Weighted average by Cap. | A |
- Stock Market
- Stocks
- BRKR Stock
- Sector Bruker Corporation
- Sector ratings
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















